Transaction DateRecipientSharesTypePriceValue
30th September 2020Management, Llc Newtyn3,850,000Disposition due to a tender of shares in a change of control transaction$0.00
30th September 2020Asset Management Lp Weiss801,424Disposition due to a tender of shares in a change of control transaction$12.00$9,617,088.00
29th September 2020Asset Management Lp Weiss100,000Open or private sale$12.74$1,273,580.00
16th June 2020Patrick K. Lucy770Exercise of derivative$3.38$2,602.60
16th June 2020Patrick K. Lucy770Open or private sale$10.23$7,873.33
2nd March 2020Patrick K. Lucy17,151Open or private sale$11.24$192,706.92
2nd March 2020Patrick K. Lucy17,151Exercise of derivative$3.38$57,970.38
27th November 2019Patrick K. Lucy3,000Open or private sale$10.03$30,104.40
16th September 2019Patrick K. Lucy250Open or private sale$10.01$2,502.50
16th September 2019Patrick K. Lucy1,800Open or private sale$10.00$18,000.00
Pfenex logo

Pfênex, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Ticker: PFNX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1478121
Employees: 81
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags